Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1670541/000167054122000074/adnt-20220805.htm
May 2023
May 2023
April 2023
March 2023
March 2023
February 2023
November 2022
November 2022
October 2022
September 2022
Three Months Ended June 30, | ||||||||||||||
(in millions, except per share data) | 2022 | 2021 | ||||||||||||
Net sales | $ | 3,485 | $ | 3,242 | ||||||||||
Cost of sales | 3,312 | 3,092 | ||||||||||||
Gross profit | 173 | 150 | ||||||||||||
Selling, general and administrative expenses | 142 | 136 | ||||||||||||
Restructuring and impairment costs | 12 | 8 | ||||||||||||
Equity income (loss) | 16 | 38 | ||||||||||||
Earnings (loss) before interest and income taxes | 35 | 44 | ||||||||||||
Net financing charges | 39 | 87 | ||||||||||||
Other pension expense (income) | (4) | (4) | ||||||||||||
Income (loss) before income taxes | — | (39) | ||||||||||||
Income tax provision (benefit) | 20 | 10 | ||||||||||||
Net income (loss) | (20) | (49) | ||||||||||||
Income attributable to noncontrolling interests | 10 | 22 | ||||||||||||
Net income (loss) attributable to Adient | $ | (30) | $ | (71) | ||||||||||
Diluted earnings (loss) per share | $ | (0.32) | $ | (0.75) | ||||||||||
Shares outstanding at period end | 94.8 | 94.2 | ||||||||||||
Diluted weighted average shares | 94.8 | 94.2 |
June 30, | September 30, | |||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Assets | ||||||||||||||
Cash and cash equivalents | $ | 892 | $ | 1,521 | ||||||||||
Accounts receivable - net | 1,761 | 1,426 | ||||||||||||
Inventories | 953 | 976 | ||||||||||||
Assets held for sale | — | 49 | ||||||||||||
Other current assets | 456 | 1,114 | ||||||||||||
Current assets | 4,062 | 5,086 | ||||||||||||
Property, plant and equipment - net | 1,443 | 1,607 | ||||||||||||
Goodwill | 2,122 | 2,212 | ||||||||||||
Other intangible assets - net | 504 | 555 | ||||||||||||
Investments in partially-owned affiliates | 348 | 335 | ||||||||||||
Assets held for sale | 7 | 25 | ||||||||||||
Other noncurrent assets | 829 | 958 | ||||||||||||
Total assets | $ | 9,315 | $ | 10,778 | ||||||||||
Liabilities and Shareholders' Equity | ||||||||||||||
Short-term debt | $ | 20 | $ | 184 | ||||||||||
Accounts payable and accrued expenses | 2,697 | 2,519 | ||||||||||||
Liabilities held for sale | — | 16 | ||||||||||||
Other current liabilities | 670 | 792 | ||||||||||||
Current liabilities | 3,387 | 3,511 | ||||||||||||
Long-term debt | 2,707 | 3,512 | ||||||||||||
Other noncurrent liabilities | 723 | 797 | ||||||||||||
Redeemable noncontrolling interests | 45 | 240 | ||||||||||||
Shareholders' equity attributable to Adient | 2,123 | 2,376 | ||||||||||||
Noncontrolling interests | 330 | 342 | ||||||||||||
Total liabilities and shareholders' equity | $ | 9,315 | $ | 10,778 |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Operating Activities | ||||||||||||||
Net income (loss) attributable to Adient | $ | (30) | $ | (71) | ||||||||||
Income attributable to noncontrolling interests | 10 | 22 | ||||||||||||
Net income (loss) | (20) | (49) | ||||||||||||
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | ||||||||||||||
Depreciation | 72 | 71 | ||||||||||||
Amortization of intangibles | 14 | 10 | ||||||||||||
Pension and postretirement benefit expense (benefit) | (3) | (1) | ||||||||||||
Pension and postretirement contributions, net | (7) | (6) | ||||||||||||
Equity in earnings of partially-owned affiliates, net of dividends received | 10 | 245 | ||||||||||||
Deferred income taxes | 13 | (2) | ||||||||||||
Non-cash restructuring and impairment charges | 1 | 1 | ||||||||||||
Equity-based compensation | 7 | 10 | ||||||||||||
Other | — | 8 | ||||||||||||
Changes in assets and liabilities: | ||||||||||||||
Receivables | (83) | 315 | ||||||||||||
Inventories | 8 | (87) | ||||||||||||
Other assets | 7 | 14 | ||||||||||||
Restructuring reserves | (11) | (23) | ||||||||||||
Accounts payable and accrued liabilities | 37 | (277) | ||||||||||||
Accrued income taxes | (22) | (7) | ||||||||||||
Cash provided (used) by operating activities | 23 | 222 | ||||||||||||
Investing Activities | ||||||||||||||
Capital expenditures | (53) | (60) | ||||||||||||
Sale of property, plant and equipment | 6 | 11 | ||||||||||||
Business acquisitions | (13) | (271) | ||||||||||||
Proceeds from business divestitures | — | 53 | ||||||||||||
Settlement of an affiliate loan | — | 15 | ||||||||||||
Cash provided (used) by investing activities | (60) | (252) | ||||||||||||
Financing Activities | ||||||||||||||
Increase (decrease) in short-term debt | — | 30 | ||||||||||||
Increase (decrease) in long-term debt | — | 214 | ||||||||||||
Repayment of long-term debt | (144) | (185) | ||||||||||||
Debt financing costs | — | (7) | ||||||||||||
Dividends paid to noncontrolling interests | (3) | (7) | ||||||||||||
Other | — | (1) | ||||||||||||
Cash provided (used) by financing activities | (147) | 44 | ||||||||||||
Effect of exchange rate changes on cash and cash equivalents | (42) | — | ||||||||||||
Increase (decrease) in cash and cash equivalents, including cash classified within current assets held for sale | (226) | 14 | ||||||||||||
Less: Change in cash classified within current assets held for sale | — | 2 | ||||||||||||
Increase (decrease) in cash and cash equivalents | $ | (226) | $ | 16 |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Net Sales | ||||||||||||||
Americas | $ | 1,673 | $ | 1,440 | ||||||||||
EMEA | 1,215 | 1,328 | ||||||||||||
Asia | 627 | 516 | ||||||||||||
Eliminations | (30) | (42) | ||||||||||||
Total net sales | $ | 3,485 | $ | 3,242 |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Adjusted EBITDA | ||||||||||||||
Americas | $ | 70 | $ | 23 | ||||||||||
EMEA | 31 | 22 | ||||||||||||
Asia | 64 | 92 | ||||||||||||
Corporate-related costs (1) | (22) | (19) | ||||||||||||
Restructuring and impairment costs (2) | (12) | (8) | ||||||||||||
Purchase accounting amortization (3) | (14) | (11) | ||||||||||||
Restructuring related charges (4) | (1) | — | ||||||||||||
Stock based compensation | (7) | (10) | ||||||||||||
Depreciation | (72) | (71) | ||||||||||||
Other items (5) | (2) | 26 | ||||||||||||
Earnings (loss) before interest and income taxes | 35 | 44 | ||||||||||||
Net financing charges | (39) | (87) | ||||||||||||
Other pension income (expense) | 4 | 4 | ||||||||||||
Income (loss) before income taxes | $ | — | $ | (39) |
Three Months Ended June 30, | ||||||||||||||
(in millions, except per share data) | 2022 | 2021 | ||||||||||||
Income available to shareholders | ||||||||||||||
Net income (loss) attributable to Adient | $ | (30) | $ | (71) | ||||||||||
Weighted average shares outstanding | ||||||||||||||
Basic weighted average shares outstanding | 94.8 | 94.2 | ||||||||||||
Effect of dilutive securities: | ||||||||||||||
Stock options, unvested restricted stock and unvested performance share awards | — | — | ||||||||||||
Diluted weighted average shares outstanding | 94.8 | 94.2 |
• | Adjusted EBIT is defined as income before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales. | ||||
• | Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and stock based compensation. Certain corporate-related costs are not allocated to the business segments in determining Adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales. Adjusted EBITDA excluding adjusted equity income, each as defined herein, is also presented. | ||||
• | Adjusted net income attributable to Adient is defined as net income attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, expenses associated with becoming an independent company, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits. | ||||
• | Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes. | ||||
• | Adjusted earnings per share is defined as Adjusted net income attributable to Adient divided by diluted weighted average shares. | ||||
• | Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or one-time items impacting equity income. | ||||
• | Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense. | ||||
• | Free cash flow is defined as cash provided by operating activities less capital expenditures. | ||||
• | Net debt is calculated as gross debt (short-term and long-term) less cash and cash equivalents. |
• | "Americas footprint actions" and "EMEA footprint actions" refer to miscellaneous closures / roll off of business. | ||||
• | "EMEA deconsolidation" refers to sale of a metals business in Turkey effective October 1, 2021 to a nonconsolidated JV in which Adient retains a noncontrolling interest. | ||||
• | "China strategic transaction" refers to the disposition of the YFAS JV and consolidation of CQADNT and LFADNT, all of which were effective on September 30, 2021. | ||||
• | "China footprint actions" refers to divestitures of smaller, non-core businesses (i.e., remaining fabrics business and Futuris entity). |
Three Months Ended June 30, | ||||||||||||||||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||||||||||||||
(in millions, except per share data) | GAAP Results | Adj. | Adjusted Results | GAAP Results | Adj. | Adjusted Results | ||||||||||||||||||||||||||||||||
Net sales | $ | 3,485 | $ | — | $ | 3,485 | $ | 3,242 | $ | — | $ | 3,242 | ||||||||||||||||||||||||||
Cost of sales (6) | 3,312 | (2) | 3,310 | 3,092 | 28 | 3,120 | ||||||||||||||||||||||||||||||||
Gross profit | 173 | 2 | 175 | 150 | (28) | 122 | ||||||||||||||||||||||||||||||||
Selling, general and administrative expenses (7) | 142 | (15) | 127 | 136 | (12) | 124 | ||||||||||||||||||||||||||||||||
Restructuring and impairment costs (2) | 12 | (12) | — | 8 | (8) | — | ||||||||||||||||||||||||||||||||
Equity income (loss) (8) | 16 | — | 16 | 38 | 1 | 39 | ||||||||||||||||||||||||||||||||
Earnings (loss) before interest and income taxes (EBIT) | 35 | 29 | 64 | 44 | (7) | 37 | ||||||||||||||||||||||||||||||||
Memo accounts: | ||||||||||||||||||||||||||||||||||||||
Depreciation | 72 | 71 | ||||||||||||||||||||||||||||||||||||
Equity based compensation | 7 | 10 | ||||||||||||||||||||||||||||||||||||
Adjusted EBITDA | $ | 143 | $ | 118 | ||||||||||||||||||||||||||||||||||
Net financing charges (9) | 39 | (2) | 37 | 87 | (38) | 49 | ||||||||||||||||||||||||||||||||
Other pension expense (income) (12) | (4) | 3 | (1) | (4) | 1 | (3) | ||||||||||||||||||||||||||||||||
Income (loss) before income taxes | — | 28 | 28 | (39) | 30 | (9) | ||||||||||||||||||||||||||||||||
Income tax provision (benefit) (10) | 20 | (11) | 9 | 10 | 7 | 17 | ||||||||||||||||||||||||||||||||
Net income (loss) attributable to Adient | (30) | 38 | 8 | (71) | 21 | (50) | ||||||||||||||||||||||||||||||||
Diluted earnings (loss) per share | (0.32) | 0.40 | 0.08 | (0.75) | 0.22 | (0.53) | ||||||||||||||||||||||||||||||||
Diluted weighted average shares | 94.8 | 0.9 | 95.7 | 94.2 | — | 94.2 |
Three months ended June 30, 2022 | ||||||||||||||||||||||||||||||||
Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
Net sales | $ | 1,673 | $ | 1,215 | $ | 627 | $ | (30) | $ | 3,485 | ||||||||||||||||||||||
Adjusted EBITDA | $ | 70 | $ | 31 | $ | 64 | $ | (22) | $ | 143 | ||||||||||||||||||||||
Adjusted EBITDA margin | 4.2 | % | 2.6 | % | 10.2 | % | N/A | 4.1 | % | |||||||||||||||||||||||
Three months ended June 30, 2021 | ||||||||||||||||||||||||||||||||
Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
Net sales | $ | 1,440 | $ | 1,328 | $ | 516 | $ | (42) | $ | 3,242 | ||||||||||||||||||||||
Adjusted EBITDA | $ | 23 | $ | 22 | $ | 92 | $ | (19) | $ | 118 | ||||||||||||||||||||||
Adjusted EBITDA margin | 1.6 | % | 1.7 | % | 17.8 | % | N/A | 3.6 | % | |||||||||||||||||||||||
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Adjusted EBITDA | $ | 143 | $ | 118 | ||||||||||
Adjusted Equity Income | 16 | 39 | ||||||||||||
Adjusted EBITDA Excluding Adjusted Equity Income | $ | 127 | $ | 79 | ||||||||||
% of Sales | 3.6 | % | 2.4 | % | ||||||||||
Three months ended June 30, | ||||||||||||||||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||||||||||||||
(in millions, except effective tax rate) | Income (loss) before income taxes | Tax impact | Effective tax rate | Income (loss) before income taxes | Tax impact | Effective tax rate | ||||||||||||||||||||||||||||||||
As reported | $ | — | $ | 20 | nm | $ | (39) | $ | 10 | (25.6)% | ||||||||||||||||||||||||||||
Adjustments (10) | 28 | (11) | (39.3)% | 30 | 7 | 23.3% | ||||||||||||||||||||||||||||||||
As adjusted | $ | 28 | $ | 9 | 32.1% | $ | (9) | $ | 17 | nm | ||||||||||||||||||||||||||||
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Net income (loss) attributable to Adient | (30) | (71) | ||||||||||||
Restructuring and impairment costs | 12 | 8 | ||||||||||||
Purchase accounting amortization | 14 | 11 | ||||||||||||
Restructuring related charges | 1 | — | ||||||||||||
Pension mark-to-market and curtailment/settlement (gain)/loss (12) | (3) | (1) | ||||||||||||
Write off of deferred financing costs upon repurchase of debt (9) | — | 10 | ||||||||||||
Derivative loss on Yanfeng transaction (9) | — | 24 | ||||||||||||
Foreign exchange loss on intercompany loan in Russia (9) | 2 | — | ||||||||||||
Premium paid on repurchase of debt (9) | — | 4 | ||||||||||||
Other items (5) | 2 | (26) | ||||||||||||
Impact of adjustments on noncontrolling interests (11) | (1) | (2) | ||||||||||||
Tax impact of above adjustments and other tax items (10) | 11 | (7) | ||||||||||||
Adjusted net income (loss) attributable to Adient | $ | 8 | $ | (50) |
Three Months Ended June 30, | ||||||||||||||
2022 | 2021 | |||||||||||||
Diluted earnings (loss) per share as reported | $ | (0.32) | $ | (0.75) | ||||||||||
Restructuring and impairment costs | 0.13 | 0.08 | ||||||||||||
Purchase accounting amortization | 0.15 | 0.12 | ||||||||||||
Restructuring related charges | 0.01 | — | ||||||||||||
Pension mark-to-market and curtailment/settlement (gain)/loss (12) | (0.03) | (0.01) | ||||||||||||
Write off of deferred financing costs upon repurchase of debt (9) | — | 0.11 | ||||||||||||
Derivative loss on Yanfeng transaction (9) | — | 0.25 | ||||||||||||
Foreign exchange loss on intercompany loan in Russia (9) | 0.02 | — | ||||||||||||
Premium paid on repurchase of debt (9) | — | 0.04 | ||||||||||||
Other items (5) | 0.02 | (0.28) | ||||||||||||
Impact of adjustments on noncontrolling interests (11) | (0.01) | (0.02) | ||||||||||||
Tax impact of above adjustments and other tax items (10) | 0.11 | (0.07) | ||||||||||||
Adjusted diluted earnings (loss) per share | $ | 0.08 | $ | (0.53) | ||||||||||
June 30, | September 30, | |||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Cash and cash equivalents | $ | 892 | $ | 1,521 | ||||||||||
Total short-term and long-term debt | 2,727 | 3,696 | ||||||||||||
Net debt | $ | 1,835 | $ | 2,175 | ||||||||||
Three Months Ended June 30, | Nine Months Ended June 30, | |||||||||||||||||||||||||
(in millions) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||
Cash provided (used) by operating activities | $ | 23 | $ | 222 | $ | 38 | $ | 362 | ||||||||||||||||||
Capital expenditures | (53) | (60) | (170) | (186) | ||||||||||||||||||||||
Free cash flow | $ | (30) | $ | 162 | $ | (132) | $ | 176 |
FY2022 | FY2021 | |||||||||||||||||||||||||
(in millions) | Q3 | YTD | Q3 | YTD | ||||||||||||||||||||||
Adjusted EBITDA excluding adjusted equity income | $ | 127 | $ | 381 | $ | 79 | $ | 613 | ||||||||||||||||||
(+) Dividend | 26 | 27 | 283 | 292 | ||||||||||||||||||||||
(-) Restructuring (cash) | (11) | (49) | (27) | (127) | ||||||||||||||||||||||
(+/-) Net customer tooling | (15) | (36) | 10 | 10 | ||||||||||||||||||||||
(+/-) Trade working capital (Net AR/AP + Inventory) | (57) | (6) | (60) | 37 | ||||||||||||||||||||||
(+/-) Accrued compensation | 2 | (45) | 27 | 35 | ||||||||||||||||||||||
(-) Interest paid | (23) | (134) | (48) | (184) | ||||||||||||||||||||||
(+/-) Tax refund/taxes paid | (25) | (63) | (20) | (52) | ||||||||||||||||||||||
(+/-) Non-income related taxes (VAT) | (20) | 33 | 5 | (73) | ||||||||||||||||||||||
(+/-) Commercial settlements | (22) | (66) | (8) | (87) | ||||||||||||||||||||||
(+/-) Capitalized engineering | 31 | 33 | (2) | 11 | ||||||||||||||||||||||
(+/-) Prepaids | 15 | (8) | (1) | (31) | ||||||||||||||||||||||
(+/-) Other | (5) | (29) | (16) | (82) | ||||||||||||||||||||||
Operating cash flow | 23 | 38 | 222 | 362 | ||||||||||||||||||||||
Capital expenditures | (53) | (170) | (60) | (186) | ||||||||||||||||||||||
Free cash flow | $ | (30) | $ | (132) | $ | 162 | $ | 176 |
Net sales | Q1 | Q2 | Q3 | Q4 | FY2021 | |||||||||||||||||||||||||||
Americas - as reported: | 1,737 | 1,644 | 1,440 | 1,343 | 6,164 | |||||||||||||||||||||||||||
Americas footprint actions | (20) | — | — | (1) | (21) | |||||||||||||||||||||||||||
Americas - pro forma | 1,717 | 1,644 | 1,440 | 1,342 | 6,143 | |||||||||||||||||||||||||||
EMEA - as reported: | 1,604 | 1,636 | 1,328 | 996 | 5,564 | |||||||||||||||||||||||||||
EMEA JV deconsolidation | (25) | (28) | (11) | (35) | (99) | |||||||||||||||||||||||||||
EMEA footprint actions | (18) | (7) | (6) | 1 | (30) | |||||||||||||||||||||||||||
EMEA - pro forma | 1,561 | 1,601 | 1,311 | 962 | 5,435 | |||||||||||||||||||||||||||
Asia - as reported: | 554 | 588 | 516 | 465 | 2,123 | |||||||||||||||||||||||||||
China strategic transactions | 234 | 199 | 231 | 227 | 891 | |||||||||||||||||||||||||||
China footprint actions | (44) | (33) | (31) | (13) | (121) | |||||||||||||||||||||||||||
Asia - pro forma | 744 | 754 | 716 | 679 | 2,893 | |||||||||||||||||||||||||||
Elimination/corporate: | (47) | (49) | (42) | (33) | (171) | |||||||||||||||||||||||||||
Total Adient - as reported | 3,848 | 3,819 | 3,242 | 2,771 | 13,680 | |||||||||||||||||||||||||||
Total Adient - pro forma | 3,975 | 3,950 | 3,425 | 2,950 | 14,300 |
Adjusted EBITDA | Q1 | Q2 | Q3 | Q4 | FY2021 | |||||||||||||||||||||||||||
Americas - as reported: | 132 | 64 | 23 | 13 | 232 | |||||||||||||||||||||||||||
Americas footprint actions | (5) | 1 | — | (1) | (5) | |||||||||||||||||||||||||||
Americas - pro forma | 127 | 65 | 23 | 12 | 227 | |||||||||||||||||||||||||||
EMEA - as reported: | 114 | 141 | 22 | — | 277 | |||||||||||||||||||||||||||
EMEA JV deconsolidation | (4) | (5) | — | (8) | (17) | |||||||||||||||||||||||||||
EMEA footprint actions | (6) | (2) | (1) | (1) | (10) | |||||||||||||||||||||||||||
EMEA - pro forma | 104 | 134 | 21 | (9) | 250 | |||||||||||||||||||||||||||
Asia - as reported: | 151 | 121 | 92 | 122 | 486 | |||||||||||||||||||||||||||
China strategic transactions | (31) | (2) | 10 | (38) | (61) | |||||||||||||||||||||||||||
China footprint actions | (7) | (5) | (2) | — | (14) | |||||||||||||||||||||||||||
Asia - pro forma | 113 | 114 | 100 | 84 | 411 | |||||||||||||||||||||||||||
Elimination/corporate: | (19) | (23) | (19) | (17) | (78) | |||||||||||||||||||||||||||
Total Adient - as reported | 378 | 303 | 118 | 118 | 917 | |||||||||||||||||||||||||||
Total Adient - pro forma | 325 | 290 | 125 | 70 | 810 |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Restructuring charges | $ | (13) | $ | (8) | ||||||||||
Held for sale asset adjustments | 1 | — | ||||||||||||
$ | (12) | $ | (8) |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Transaction costs | $ | (2) | $ | (2) | ||||||||||
Brazil indirect tax recoveries | 1 | 28 | ||||||||||||
Disposal of non-core assets | (1) | — | ||||||||||||
$ | (2) | $ | 26 |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Restructuring related charges | $ | (1) | $ | — | ||||||||||
Brazil indirect tax recoveries | 1 | 28 | ||||||||||||
Purchase accounting amortization | (1) | — | ||||||||||||
Disposal of non-core assets | (1) | — | ||||||||||||
$ | (2) | $ | 28 |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Purchase accounting amortization | $ | (13) | $ | (10) | ||||||||||
Transaction costs | (2) | (2) | ||||||||||||
$ | (15) | $ | (12) |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Purchase accounting amortization | — | 1 | ||||||||||||
$ | — | $ | 1 |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Derivative loss on Yanfeng transaction | $ | — | $ | (24) | ||||||||||
Premium paid on repurchase of debt | — | (4) | ||||||||||||
Write off of deferred financing costs upon repurchase of debt | — | (10) | ||||||||||||
Foreign exchange loss on intercompany loan in Russia | (2) | — | ||||||||||||
$ | (2) | $ | (38) |
Three Months Ended June 30, | ||||||||||||||
(in millions) | 2022 | 2021 | ||||||||||||
Benefits associated with restructuring and impairment charges | $ | — | $ | (2) | ||||||||||
Brazil indirect tax recoveries | — | 9 | ||||||||||||
Withholding tax adjustments | — | (11) | ||||||||||||
Valuation allowances | 12 | — | ||||||||||||
Other reconciling items | (1) | (3) | ||||||||||||
$ | 11 | $ | (7) |
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1670541/000167054122000074/adnt-20220805.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Adient Plc.
Adient Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Material Contracts, Statements, Certifications & more
Adient Plc provided additional information to their SEC Filing as exhibits
Ticker: ADNTEvents:
CIK: 1670541
Form Type: 8-K Corporate News
Accession Number: 0001670541-22-000074
Submitted to the SEC: Fri Aug 05 2022 6:54:29 AM EST
Accepted by the SEC: Fri Aug 05 2022
Period: Friday, August 5, 2022
Industry: Motor Vehicle Parts And Accessories